GE Healthcare to Invest $1 Billion in New Oncology Solutions General Electric (GE) Healthcare announced its plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research. [BusinessWire] Press Release
Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.